Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
FARALLON CAPITAL MANAGEMENT LLC TNGX Tango Therapeutics, Inc. 13G/A 9.8% 3mo
Keith Crandell MASS 908 Devices Inc. 13G/A 14.1% 3mo
Anson Funds Management LP NXAT Nexus Advanced Technologies Inc. 13G/A 1.3% 3mo
BROWN ADVISORY INC ANDG Andersen Group Inc. 13G/A 16.64% 3mo
BRC Group Holdings, Inc. DDI DoubleDown Interactive Co., Ltd. 13G/A 3.64% 3mo
Brannin McBee CRWV CoreWeave, Inc. 13G/A 2.9% 3mo
Balyasny Asset Management L.P. JATT JATT II Acquisition Corp. 13G 6.23% 3mo
ARISTEIA CAPITAL, L.L.C. ARCL ARC Group Acquisition I Corp. 13G 7.84% 3mo
Legal & General Group Plc FCEL Fuelcell Energy Inc 13G/A 3.6% 3mo
Polar Asset Management Partners Inc. RANG Range Capital Acquisition Corp. 13G/A 1.6% 3mo
Deep Track Capital, LP MBX MBX Biosciences, Inc. 13G/A 3.64% 3mo
Empyrean Capital Partners, LP AGLT Agility Robotics, Inc. 13G 7.52% 3mo
Harraden Circle Investments, LLC ENHA Enhanced Group Inc. 13G/A 0% 3mo
Alyeska Investment Group, L.P. PEB Pebblebrook Hotel Trust 13G/A 2.16% 3mo
Point72 Asset Management, L.P. DSGN Design Therapeutics, Inc. 13G/A 3.8% 3mo
First Trust Capital Management L.P. ALF Centurion Acquisition Corp. 13G/A 0% 3mo
CORSAIR CAPITAL MANAGEMENT, L.P. CNVS Cineverse Corp. 13G/A 3.9% 3mo
North Reef Capital Management LP SBCF Seacoast Banking Corp Of Florida 13G/A 4.91% 3mo
Vestal Point Capital, LP GLUE Monte Rosa Therapeutics, Inc. 13G 5.4% 3mo
Khrom Investments Fund, LP ACHC Acadia Healthcare Company, Inc. 13G/A 0.72% 3mo
DISCIPLINED GROWTH INVESTORS INC /MN AIOT Powerfleet, Inc. 13G/A 4.7% 3mo
Kenneth Griffin HIVE HIVE Digital Technologies Ltd. 13G/A 4.2% 3mo
CP BF Lending, LLC PARA Parabolic Technologies, Inc. 13G 24.8% 3mo
D. E. Shaw & Co., L.P. ARVN Arvinas, Inc. 13G/A 5.4% 3mo
Brian Venturo CRWV CoreWeave, Inc. 13G/A 3.6% 3mo
Alyeska Investment Group, L.P. BKKT Bakkt, Inc. 13G/A 0% 3mo
MORGAN STANLEY BRCB Black Rock Coffee Bar, Inc. 13G/A 8.2% 3mo
Harraden Circle Investments, LLC BREZ Breeze Acquisition Corp. II 13G/A 0% 3mo
Karpus Management, Inc. DMAA Drugs Made In America Acquisition Corp. 13G/A 10.33% 3mo
Vestal Point Capital, LP NRIX Nurix Therapeutics, Inc. 13G/A 7.8% 3mo
Pentwater Capital Management LP AMC Amc Entertainment Holdings, Inc. 13G/A 0.3% 3mo
Driehaus Capital Management LLC FEIM Frequency Electronics Inc 13G 7.18% 3mo
Sirenia Capital Management LP IFRX InflaRx N.V. 13G 6.1% 3mo
First Light Asset Management, LLC PVLA Palvella Therapeutics, Inc. 13G/A 5.34% 3mo
Sirenia Capital Management LP DNTH Dianthus Therapeutics, Inc. 13G/A 3.1% 3mo
Fort Baker Capital Management LP CCII Cohen Circle Acquisition Corp. II 13G/A 9.8% 3mo
Sirenia Capital Management LP HELP Helus Pharma Inc. 13G/A 4.8% 3mo
Polar Asset Management Partners Inc. IXHL Incannex Healthcare Inc. 13G 7% 3mo
CastleKnight Master Fund LP INV Innventure, Inc. 13G/A 4.7% 3mo
Deep Track Capital, LP VRDN Viridian Therapeutics, Inc.\DE 13G/A 3.25% 3mo
METEORA CAPITAL, LLC HCAC Hall Chadwick Acquisition Corp 13G/A 5.22% 3mo
METEORA CAPITAL, LLC VNME Vendome Acquisition Corp I 13G/A 9.81% 3mo
Rubric Capital Management LP MGTX MeiraGTx Holdings plc 13G/A 9.83% 3mo
Greenoaks Capital Partners LLC NAVN Navan, Inc. 13G/A 0.42% 3mo
Solas Capital Management, LLC SNWV SANUWAVE Health, Inc. 13G/A 7.1% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ ARGX Argenx SE 13G/A 4.3% 3mo
Encompass Capital Advisors LLC AESI Atlas Energy Solutions Inc. 13G/A 5.24% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC MYX Maywood Acquisition Corp. 2 13G 7.3% 3mo
Point72 Asset Management, L.P. PSIX Power Solutions International, Inc. 13G/A 6.5% 3mo
ARMISTICE CAPITAL, LLC GOVX GeoVax Labs, Inc. 13G/A 4.99% 3mo